613
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors

, , , , , & show all
Pages 221-230 | Accepted 09 Nov 2012, Published online: 27 Nov 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Francisco Batel Marques, Ana Penedones, Diogo Mendes & Carlos Alves. (2016) A systematic review of observational studies evaluating costs of adverse drug reactions. ClinicoEconomics and Outcomes Research 8, pages 413-426.
Read now

Articles from other publishers (7)

Yanmei Peng, Qiang Li, Jingyi Zhang, Wen Shen, Xu Zhang, Chenyao Sun & Huijuan Cui. (2018) Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors. BioScience Trends 12:6, pages 537-552.
Crossref
Janette Beech, Theodora Germetaki, Mary Judge, Nina Paton, Joanne Collins, Abigail Garbutt, Michael Braun, Jill FenwickMark P Saunders. (2018) Management and grading of EGFR inhibitor-induced cutaneous toxicity. Future Oncology 14:24, pages 2531-2541.
Crossref
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Talia Foster & Chris L. Pashos. (2014) The Economic Burden of Head and Neck Cancer: A Systematic Literature Review. PharmacoEconomics 32:9, pages 865-882.
Crossref
Beth Eaby-Sandy & Kathy Lynch. (2014) Side Effects of Targeted Therapies: Rash. Seminars in Oncology Nursing 30:3, pages 147-154.
Crossref
Jung-Won Park. (2014) Social Burden of Drug Allergy and its Prevention. Korean Journal of Medicine 87:6, pages 647.
Crossref
Kamran Bagheri Lankarani. (2013) Why Colorectal Diseases are Important?. Annals of Colorectal Research 1:1, pages 1-2.
Crossref
Kamran Bagheri Lankarani. (2013) Why Colorectal Diseases are Important?. Annals of Colorectal Research 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.